| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 03/12/2002 | US6355270 Particles for oral delivery of peptides and proteins |
| 03/12/2002 | US6355255 Streptococcal C5a peptidase vaccine |
| 03/12/2002 | US6355254 Pathogenic Escherichia coli associated protein EspA |
| 03/12/2002 | US6355252 Antiinflammatory agents |
| 03/12/2002 | US6355248 Method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 03/12/2002 | US6355247 Nucleic acid immunization using a virus-based infection/transfection system |
| 03/12/2002 | US6355245 Glomerulonephritis,antibodies at low dosage |
| 03/12/2002 | US6355244 Methods and compositions for the treatment of psoriasis |
| 03/12/2002 | US6355241 In vivo production and delivery of erythropoietin |
| 03/12/2002 | US6355240 Genetic engineering |
| 03/12/2002 | CA2357081A1 Retroviral vectors with foreign-sequence insertion between retroviral primer binding site and retroviral splice donor |
| 03/12/2002 | CA2189657C Lag-3 protein soluble polypeptide fractions, method of production, therapeutic composition and anti-idiotype antibody |
| 03/12/2002 | CA2159103C Detection of human immunodeficiency virus type 1 |
| 03/12/2002 | CA2034741C Therapeutic antibody based fusion proteins |
| 03/12/2002 | CA1341347C Androgen receptor proteins, recombinant dna molecules coding for such, and use of such compositions |
| 03/12/2002 | CA1341346C Antisense gene systems of pollination control for hybrid seed production |
| 03/08/2002 | CA2357404A1 Method for growing or for removing circoviruses from biological material |
| 03/07/2002 | WO2002018948A2 Differentially expressed epitopes and uses thereof |
| 03/07/2002 | WO2002018938A1 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 03/07/2002 | WO2002018659A2 Method for determining alleles |
| 03/07/2002 | WO2002018643A2 Nanoparticles having oligonucleotides attached thereto and uses therefor |
| 03/07/2002 | WO2002018637A2 Diagnosis and treatment of prostate cancer |
| 03/07/2002 | WO2002018636A2 Improvements in and relating to marking using dna |
| 03/07/2002 | WO2002018635A2 Use of nonviable particles comprising an internal control (ic) nucleic acid |
| 03/07/2002 | WO2002018633A2 Determination of the ability of patients to respond to tumour treatment |
| 03/07/2002 | WO2002018632A2 Method for determining the degree of methylation of defined cytosines in genomic dna in the sequence context 5'-cpg-3' |
| 03/07/2002 | WO2002018631A2 Diagnosis of illnesses or predisposition to certain illnesses |
| 03/07/2002 | WO2002018629A1 Degenerate oligonucleotide gene shuffling |
| 03/07/2002 | WO2002018621A2 Glut10: a novel glucose transporter in the type 2 diabetes linked region of chromosome 20q12-13.1 |
| 03/07/2002 | WO2002018620A2 Neutrokine-alpha and neutrokine-alpha splice variant |
| 03/07/2002 | WO2002018619A2 Nucleic acid constructs including a novel t-cell active promoter, and pharmaceutical compositions and methods utilizing same for regulating t-cell mediated immune response |
| 03/07/2002 | WO2002018617A2 Carotenoid production by recombinant, c1-metabolizing methanothropic bacteria |
| 03/07/2002 | WO2002018615A1 Methods for reducing complexity of nucleic acid samples |
| 03/07/2002 | WO2002018613A1 NUCLEOTIDE SEQUENCES WHICH CODE FOR THE metY GENE |
| 03/07/2002 | WO2002018611A2 Method for the improved production and isolation of trans-dihydroxycyclohexadiene carboxylic acids and/or derivatives thereof and a genetically modified organism suitable for the above |
| 03/07/2002 | WO2002018609A2 Methods for stable transduction of cells with viral vectors |
| 03/07/2002 | WO2002018608A2 Methods for enhancing the efficacy of cancer therapy |
| 03/07/2002 | WO2002018607A2 Transgenic plants containing molecular decoys that alter protein content therein |
| 03/07/2002 | WO2002018606A1 Novel starches produced by the expression of heterologous granule bound starch synthase genes |
| 03/07/2002 | WO2002018605A2 Anti-microbial agents |
| 03/07/2002 | WO2002018604A2 Methods and compositions for determining isomerase enzymatic activity |
| 03/07/2002 | WO2002018603A1 Isomaltulose synthase |
| 03/07/2002 | WO2002018602A1 Novel polypeptide |
| 03/07/2002 | WO2002018601A2 Essential bacteria genes and genome scanning in haemophilus influenzae for the identification of 'essential genes' |
| 03/07/2002 | WO2002018600A1 Groes and groel homologs of francisella tularensis |
| 03/07/2002 | WO2002018599A1 Nucleotide sequences coding for the sigm gene |
| 03/07/2002 | WO2002018598A1 Nucleotide sequences which code for the sigh gene |
| 03/07/2002 | WO2002018597A1 Nucleotide sequences which code for the csta gene from corynebacterium glutamicum |
| 03/07/2002 | WO2002018596A1 Citb gene from corynebacteria and use thereof in synthesis of l-amino acids |
| 03/07/2002 | WO2002018595A2 Moraxella polypeptides and corresponding dna fragments and uses thereof |
| 03/07/2002 | WO2002018594A1 ZEBRAFISH HuC PROMOTER CAPABLE OF DIRECTING NEURON-SPECIFIC EXPRESSION OF STRUCTURAL GENES, TRANSGENIC ANIMAL HAVING HuC PROMOTER AND ITS GENERATION, AND METHOD FOR SCREENING NEURONAL MUTANT ANIMALS USING THE TRANSGENIC ANIMAL |
| 03/07/2002 | WO2002018593A2 Modulation of fas and fasl expression |
| 03/07/2002 | WO2002018591A1 Method of performing reverse transcription reaction using reverse transcriptase encoded by non-ltr retrotransposable element |
| 03/07/2002 | WO2002018590A2 Identification of activated receptors and ion channels |
| 03/07/2002 | WO2002018588A1 Method for screening highly active proteases and inhibitors |
| 03/07/2002 | WO2002018587A1 Process for producing biopterins |
| 03/07/2002 | WO2002018585A2 Packaging of positive-strand rna virus replicon particles |
| 03/07/2002 | WO2002018584A2 Xage-1, a gene expressed in multiple cancers, and uses thereof |
| 03/07/2002 | WO2002018583A2 Modified polypeptides stabilized in a desired conformation and methods for producing same |
| 03/07/2002 | WO2002018582A2 62112, a novel human dehydrogenase and uses thereof |
| 03/07/2002 | WO2002018581A2 G-protein coupled receptors |
| 03/07/2002 | WO2002018580A2 54372, a novel human anion transporter and uses therefor |
| 03/07/2002 | WO2002018579A2 57242, a novel human g protein-coupled receptor family member and uses therefor |
| 03/07/2002 | WO2002018577A2 48921, a novel human gtp releasing factor and uses therefor |
| 03/07/2002 | WO2002018576A2 Compositions and methods relating to lung specific genes |
| 03/07/2002 | WO2002018575A2 Genes expressed in the cell cycle |
| 03/07/2002 | WO2002018574A2 Human interleukin-four induced protein |
| 03/07/2002 | WO2002018573A2 54370, a novel human sulfate transporter and uses therefor |
| 03/07/2002 | WO2002018572A2 Membrane penetrating peptides and uses thereof |
| 03/07/2002 | WO2002018570A1 Yeast transformant producing recombinant human parathyroid hormone and method for producing the hormone |
| 03/07/2002 | WO2002018569A2 Methods for preparing human thrombopoietin polypeptides by mammalian cell cultures |
| 03/07/2002 | WO2002018568A2 Molecules involved in the regulation of insulin in resistance syndrome (irs) |
| 03/07/2002 | WO2002018567A2 Regulation of human aminotransferase-like enzyme |
| 03/07/2002 | WO2002018566A2 Regulation of human l-asparaginase-like enzyme |
| 03/07/2002 | WO2002018562A1 Airway-specific trypsin-like enzymes and method of using the same |
| 03/07/2002 | WO2002018561A2 Modified fungal xylanases |
| 03/07/2002 | WO2002018560A2 Butinol i esterase |
| 03/07/2002 | WO2002018559A2 50566, human glyoxalase ii related factor and uses thereof |
| 03/07/2002 | WO2002018558A2 27439, a human hydroxylase and uses therefor |
| 03/07/2002 | WO2002018557A2 Human kinases |
| 03/07/2002 | WO2002018556A2 8797, a human galactosyltransferase and uses thereof |
| 03/07/2002 | WO2002018555A2 Human kinase proteins and polynucleotides encoding the same |
| 03/07/2002 | WO2002018554A2 Isolated human drug-metabolizing proteins, nucleic acid moleculesand uses thereof |
| 03/07/2002 | WO2002018553A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 03/07/2002 | WO2002018552A2 Regulation of human aminotransferase-like enzyme |
| 03/07/2002 | WO2002018550A1 Selective precipitation of viruses |
| 03/07/2002 | WO2002018548A2 Tyrosine hydroxylase 5' control elements and uses thereof |
| 03/07/2002 | WO2002018547A1 Methods for reducing polyamine biosynthesis and the plants and seeds produced thereby |
| 03/07/2002 | WO2002018541A2 A neural specific cystosolic sulfotransferase for drug screening |
| 03/07/2002 | WO2002018538A2 PROTOCOLS FOR THE GENERATION OF HIGH YIELD, SUPER-PRODUCTIVE TRANSGENIC PLANTS DISTURBED IN Ran/Ran-BINDING PROTEINS-MEDIATED CELLULAR PROCESS |
| 03/07/2002 | WO2002018537A2 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents |
| 03/07/2002 | WO2002018536A2 Truncated bard1 protein, and its diagnostic and therapeutic uses |
| 03/07/2002 | WO2002018444A2 Erbb4 antagonists |
| 03/07/2002 | WO2002018443A2 A recombinant monoclonal antibody to phosphotyrosine-containing proteins |
| 03/07/2002 | WO2002018440A1 Anti-angiogenic peptides |
| 03/07/2002 | WO2002018438A1 Modified proteins, isolated novel peptides, and uses thereof |
| 03/07/2002 | WO2002018435A1 18 human secreted proteins |
| 03/07/2002 | WO2002018426A2 Rabbit hemorrhagic disease vaccine and antigens |
| 03/07/2002 | WO2002018425A2 '47324', a novel g-protein and uses therefor |
| 03/07/2002 | WO2002018424A2 Nucleic acids and polypeptides |